Prognostic Factors in Patients with Rocky Mountain Spotted Fever
Keywords:Rocky Mountain Spotted Fever, Rickettsia rickettsii, Mortality, Acute kidney injury, Necrosis
Background: Rocky Mountain Spotted Fever (RMSF) is a disease with a high mortality rate, caused by Rickettsia rickettsii, a bacteria transmitted to humans by infected ticks. In 2008 there was a Rocky Mountain Spotted Fever (RMSF) outbreak in the city of Mexicali, México, resulting in an increased mortality rate amongst the area population.
Methods: Case-series study of patients admitted to the General Hospital of Mexicali between 2014 and 2019 with a confirmed diagnosis of RMSF. Mortality was compared dividing the population on those ?20 and younger than ?21 years of age.
Results: A total of 129 patients’ records during a 5-year period whose diagnosis was RMSF confirmed with PCR were included. Mortality was compared among patients admitted who were younger than ?20 years of age with that among patients who were older than ?20 years of age (61 versus 68 respectively), the latter being higher with an OR 4.2 (p<0.0001).
Conclusion: RMSF in hospitalized patients has a high mortality rate in spite of early treatment in all age groups, without showing any predominance in gender. However, patients older than 20 years of age had a higher mortality rate than those younger than 20 years, without any predominance in gender.
Snowden S, Simonsen KA. Rickettsia Rickettsiae (Rocky Mountain Spotted Fever). StatPearls Publishing; 2020.
Sanchez-Montes S, Lopez-Perez AM, Guzman-Cornejo C, Colunga-Salas P, Becker I, Delgado-de la Mora- J, et al. Rickettsia parkeri in Dermacentor parumapertus Ticks, México. Emerg Infect Dis. 2018 Jun;24(6):1108-1111.
Álvarez-Hernández G, Candia-Plata MC, Delgado-de la Mora J, Acuña-Melendrez NH, Vargas-Ortega AP, Licona-Enríquez JD. Fiebre maculosa de las Montañas Rocosas en niños y adolescentes mexicanos: cuadro clinico y factores de mortalidad Salud Publica Mex 2016;58:385-392. Spanish.
Pavanelo DR, Schroder NCH, Pin Viso ND, Martins LA, Malossi CD, Galleti MFBM, et al. Comparative analysis of the midgut microbiota of two natural tick vector of Rickettsia rickettsia. Dev Comp Immunol. 2020; 106:103606.
Barba JR. Fiebre manchada de las Montañas Rocosas. Revista Mexicana de Patologia Clinica. 2009; 56(3):193-208. Spanish.
Parola P, Paddock CD, Socolovschi C, Labruna MB, Mediannikov O, Kernif T, et al. Update on Tick-Borne Rickettsioses around the World: a Geographic Approach. Clin Microbiol Rev. 2013;26(4):657–702.
Traeger MS, Regan JJ, Humpherys D, Mahoney DL, Martinez M, Emerson GL, et al. Risk Factors for Fatal Outcome From Rocky Mountain Spotted Fever in a Highly Endemic Area—Arizona, 2002–2011. Clin Infect Dis. 2015; 60(11):1659–66.
Jaramillo HJ, Rodriguez M. Ricketsiosis. Presentacion de dos casos, en medio de un brote en Mexicali, Baja California. Medicina Interna de México. 2010; 26(2):180-2. Spanish.
Paddock CD, Denison AM, Lash RR, Liu L, Bollweg BC, Dahlgren FS. Phylogeography of Rickettsia rickettsii Genotypes Associated with Fatal Rocky Mountain Spotted Fever. Am J Trop Med Hyg. 2014;91(3):589-97.
Gottlieb M, Long B, Koyfman A. The Evaluation and Management of Rocky Mountain Spotted Fever in the Emergency Department: a Review of the Literature. J Emerg Med. 2018 Jul;55(1):42-50.
Moore JJ. Time relationships of the wood-tick in the transmission of Rocky Mountain spotted fever. J Infect Dis 1911; 8: 339–47.
Ramos-e-Silva M, Pereira AL. Life Threatening Eruptions Due to Infectious Agents. Clin Dermatol. 2005; 23(2):148-56.
Denison AM, Amin BD, Nicholson WL, Paddock CD. Detection of Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari in skin biopsy specimens using a multiplex real-time polymerase chain reaction assay. Clin Infec Dis. 2014; 59(5):635-642.
Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/dpdx/ticks/index.html. Atlanta: c2019. Cited Nov 19, 2019.
Ed. E. Maxey, G T McCullough, J W Leary. Some Observations on the So-called Spotted Fever of Idaho. 1st ed. 1899.
How to Cite
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to firstname.lastname@example.org
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to email@example.com